232 related articles for article (PubMed ID: 17908631)
21. [The health state evaluation in persons after therapy of Hodgkin's disease in childhood: report of the Polish Pediatric Leukemia/Lymphoma Study Group].
Balwierz W; Moryl-Bujakowska A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Sopyło B; Stańczak E; Sońta-Jakimczyk D; Janik-Moszant A; Chybicka A; Chaber R; Kowalczyk JR; Odój T; Balcerska A; Stachowicz-Stencel T; Wysocki M; Kołtan A; Kołtan S; Krawczuk-Rybak M; Muszyńska-Rosłan K; Zuj G;
Przegl Lek; 2006; 63(1):25-8. PubMed ID: 16892895
[TBL] [Abstract][Full Text] [Related]
22. New strategies for the treatment of advanced-stage Hodgkin's lymphoma.
Diehl V; Engert A; Re D
Hematol Oncol Clin North Am; 2007 Oct; 21(5):897-914. PubMed ID: 17908627
[TBL] [Abstract][Full Text] [Related]
23. Second cancers in survivors of hodgkin lymphoma: risks and recommendations.
Leahy Y
Clin J Oncol Nurs; 2008 Jun; 12(3):437-42. PubMed ID: 18515242
[TBL] [Abstract][Full Text] [Related]
24. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
[TBL] [Abstract][Full Text] [Related]
25. Pediatric Hodgkin's lymphoma: changing concepts and moving points in radiation therapy.
Khafaga YM; Belgaumi AF
Transfus Apher Sci; 2013 Aug; 49(1):56-62. PubMed ID: 23769169
[TBL] [Abstract][Full Text] [Related]
26. Quality of life in people with Hodgkin's disease.
Yellen SB; Cella DF; Bonomi A
Oncology (Williston Park); 1993 Aug; 7(8):41-5; discussion 46, 50-2. PubMed ID: 8398634
[TBL] [Abstract][Full Text] [Related]
27. Role of radiation therapy in Hodgkin's lymphoma.
Yahalom J
Cancer J; 2009; 15(2):155-60. PubMed ID: 19390312
[TBL] [Abstract][Full Text] [Related]
28. Salvage therapy for Hodgkin's lymphoma.
Quddus F; Armitage JO
Cancer J; 2009; 15(2):161-3. PubMed ID: 19390313
[TBL] [Abstract][Full Text] [Related]
29. [Long-term toxicity of curative lymphoma therapy].
Gassmann W; Slanina J
Internist (Berl); 1993 Feb; 34(2):161-9. PubMed ID: 8454430
[No Abstract] [Full Text] [Related]
30. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; Béron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
[TBL] [Abstract][Full Text] [Related]
31. Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
Hodgson DC; Hudson MM; Constine LS
Semin Radiat Oncol; 2007 Jul; 17(3):230-42. PubMed ID: 17591570
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin's disease: complications of therapy and excess mortality.
Hoppe RT
Ann Oncol; 1997; 8 Suppl 1():115-8. PubMed ID: 9187444
[TBL] [Abstract][Full Text] [Related]
33. The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience.
Olcese F; Clavio M; Rossi E; Spriano M; Ballerini F; Canepa L; Pierri I; Aquino S; Varaldo R; Manna A; Secondo V; Racchi O; Balleari E; Orcioni GF; Carella AM; Ghio R; Gobbi M
Ann Hematol; 2009 Sep; 88(9):855-61. PubMed ID: 19189105
[TBL] [Abstract][Full Text] [Related]
34. Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.
Dutton A; Burns AT; Young LS; Murray PG
Expert Rev Anticancer Ther; 2006 Jun; 6(6):911-9. PubMed ID: 16761935
[TBL] [Abstract][Full Text] [Related]
35. Advances in the treatment of Hodgkin lymphoma.
Mauch P
Clin Adv Hematol Oncol; 2006 Sep; 4(9):652-4, 675. PubMed ID: 17099620
[No Abstract] [Full Text] [Related]
36. Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma.
Oguz A; Tayfun T; Citak EC; Karadeniz C; Tatlicioglu T; Boyunaga O; Bora H
Pediatr Blood Cancer; 2007 Oct; 49(5):699-703. PubMed ID: 17420991
[TBL] [Abstract][Full Text] [Related]
37. What is the price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients.
Zsófia M; Katalin K; Judit V; György S; Arpád I
Hematol Oncol; 2007 Dec; 25(4):178-83. PubMed ID: 17607807
[TBL] [Abstract][Full Text] [Related]
38. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN
J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149
[TBL] [Abstract][Full Text] [Related]
39. Salvage therapy in Hodgkin's lymphoma.
Mendler JH; Friedberg JW
Oncologist; 2009 Apr; 14(4):425-32. PubMed ID: 19342476
[TBL] [Abstract][Full Text] [Related]
40. [Multiple organ failure in patients with hemoblastosis during long-term follow-up of treatment].
Loseva MI; Pospelova TN; Gavalova RF; Kurilovich SA; Soldatova GS; Purtova LA; Ianushkevich LA; Ageeva TA; Netesova IG; Mordvov SA
Ter Arkh; 1999; 71(7):39-42. PubMed ID: 10481866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]